Pages that link to "Q57334398"
Jump to navigation
Jump to search
The following pages link to Jason Robarge (Q57334398):
Displaying 13 items.
- A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis (Q28183038) (← links)
- Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy. (Q33630784) (← links)
- Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis (Q34603580) (← links)
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors (Q34847405) (← links)
- Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy (Q36693164) (← links)
- Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons. (Q36927755) (← links)
- Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy (Q37103134) (← links)
- Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients (Q37278456) (← links)
- Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects (Q37279259) (← links)
- Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer (Q47594270) (← links)
- Pharmacogenetics and healthcare outcomes in patients with chronic heart failure. (Q47834875) (← links)
- Variable hand and foot abnormalities in family with congenital vertical talus and CDMP-1 gene mutation (Q61647685) (← links)
- Association of polymorphisms of angiogenesis genes with breast cancer (Q81344086) (← links)